Vaccination elicits immune responses capable of potently neutralizing SARS-CoV-2. However,
ongoing surveillance has revealed the emergence of variants harboring mutations in …

Recent surveillance has revealed the emergence of the SARS-CoV-2 Omicron variant (BA.1/B.1.1.529)
harboring up to 36 mutations in spike protein, the target of neutralizing antibodies…

Introduction Many genetic variants associated with common disease susceptibility occur
close to immune-related genes in noncoding DNA, suggestive of a regulatory function. The …

Background Understanding immunogenicity and effectiveness of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) vaccines is critical to guide rational use. Methods We …

Abstract Treatment with immune checkpoint blockade (ICB) frequently triggers immune-related
adverse events (irAEs), causing considerable morbidity. In 214 patients receiving ICB for …

Neutrophils form the most abundant leukocyte subset and are central to many disease
processes. Technical challenges in transcriptomic profiling have prohibited genomic approaches …

The SARS-CoV-2 Omicron variant (B.1.1.529) contains mutations that mediate escape from
antibody responses, although the extent to which these substitutions in spike and non-spike …

Background. Women in Africa, especially young women, have very high human immunodeficiency
virus (HIV) incidence rates that cannot be fully explained by behavioral risks. We …

Anti-PD-1/PD-L1 agents have transformed the treatment landscape of advanced non-small
cell lung cancer (NSCLC). To expand our understanding of the molecular features underlying …

Immune checkpoint inhibitors (ICIs) have yielded remarkable responses but often lead to
immune-related adverse events (irAEs). Although germline causes for irAEs have been …